We are live on ! Find out more
AERI

Aerie Pharmaceuticals
AERI

Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

Fund managers haven’t disclosed any holdings of AERI yet.

AERI Hedge Fund Activity: Q4 2022 in Review

0 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Aerie Pharmaceuticals (AERI) for Q4 2022, worth a combined $0 — down 100% from $703M a quarter earlier.

Sellers outnumbered buyers: 153 funds closed out of AERI and 0 opened new positions — a net loss of 153 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Deerfield Management, exiting entirely with an estimated $73.5M sold.

  • 0 institutional investors held Aerie Pharmaceuticals (AERI) as of Q4 2022, down from 156 in Q3 2022.
  • Funds reported $0 of Aerie Pharmaceuticals stock for Q4 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Aerie Pharmaceuticals positions in Q4 2022 and 153 closed out, a net change of -153 holders.
  • The largest Aerie Pharmaceuticals seller in Q4 2022 was Deerfield Management, an estimated $73.5M sold.

Based on aggregated 13F filings for Q4 2022.